Stress and IL-1Β contribute to the development of depressive-like behavior following peripheral nerve injury

Molecular Psychiatry

Volumn 15, Issue 4, 2010, Pages 404-414

  Norman, G J ^a   Karelina, K ^a   Zhang, N ^a   Walton, J C ^a   Morris, J S ^a   Devries, A C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Depressive like behavior; Glucocorticoid; Interleukin 1b; Neuropathic pain; Spared nerve injury; Stress

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; METYRAPONE; CYTOKINE; MESSENGER RNA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DISEASE COURSE; DRUG ACTIVITY; DRUG INHIBITION; ENCEPHALITIS; FRONTAL CORTEX; GENE EXPRESSION; MALE; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HYPERALGESIA; MENTAL STRESS; METABOLISM; PAIN THRESHOLD; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SWIMMING; TIME;

ANALYSIS OF VARIANCE; ANIMALS; CORTICOSTERONE; CYTOKINES; DEPRESSION; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; HYPERALGESIA; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SWIMMING; TIME FACTORS;

EID: 77950020374     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2009.91     Document Type: Article

References (58)

1. Wise TN, Fishbain DA, Holder-Perkins V. Painful physical symptoms in depression: a clinical challenge. Pain Med 2007; 8(Suppl 2): S75-S82.
2. Strouse TB. The relationship between cytokines and pain/depression: a review and current status. Curr Pain Headache Rep 2007; 11: 98-103.
3. Jensen MP, Chodroff MJ, Dworkin RH. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology 2007; 68: 1178-1182.
4. Gatchel RJT. D.C. Psychological Approaches to Pain Management: A Practitioner's Handbook, Guilford Press: New York, 1996 Classification of Chronic Pain. Proceedings of the IASP Task Force on Taxonomy. IASP Press. Seattle, 1994.
5. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004; 63: 2104-2110.
6. Wilkie DJ, Huang HY, Reilly N, Cain KC. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage 2001; 22: 899-910.
7. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999; 96: 7687-7692.
8. Vanegas H, Schaible HG. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev 2004; 46: 295-309.
9. Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004; 27: 729-737.
10. Neugebauer V, Li W, Bird GC, Han JS. The amygdala and persistent pain. Neuroscientist 2004; 10: 221-234.
11. Xu H, Wu LJ, Wang H, Zhang X, Vadakkan KI, Kim SS et al. Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J Neurosci 2008; 28: 7445-7453.
12. Apkarian AV, Lavarello S, Randolf A, Berra HH, Chialvo DR, Besedovsky HO et al. Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain. Neurosci Lett 2006; 407: 176-181.
13. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R (eds), Textbook of Pain, 4th edn. Churchill Livingston: Edinburgh, 1999, pp 309-329
14. Rhudy JL, Williams AE, McCabe KM, Nguyen MA, Rambo P. Affective modulation of nociception at spinal and supraspinal levels. Psychophysiology 2005; 42: 579-587.
15. Villemure C, Bushnell MC. Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain 2002; 95: 195-199.
16. Dworkin RH, Gitlin MJ. Clinical aspects of depression in chronic pain patients. Clin J Pain 1991; 7: 79-94.
17. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31.
18. Watkins LR, Maier SF. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 2005; 257: 139-155.
19. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-389.
20. McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary- adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum 2007; 56: 360-371.
21. Wood PB. Stress and dopamine: implications for the patho-physiology of chronic widespread pain. Med Hypotheses 2004; 62: 420-424.
22. da Silva Torres IL, Cucco SN, Bassani M, Duarte MS, Silveira PP, Vasconcellos AP et al. Long-lasting delayed hyperalgesia after chronic restraint stress in rats-effect of morphine administration. Neurosci Res 2003; 45: 277-283.
23. Cerqueira JJ, Pego JM, Taipa R, Bessa JM, Almeida OF, Sousa N. Morphological correlates of corticosteroid-induced changes in prefrontal cortex-dependent behaviors. J Neurosci 2005; 25: 7792-7800.
24. Mitra R, Sapolsky RM. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci USA 2008; 105: 5573-5578.
25. Bourquin AF, Suveges M, Pertin M, Gilliard N, Sardy S, Davison AC et al. Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse. Pain 2006; 122, 14.e1-14
26. Tal M, Bennett GJ. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain 1994; 57: 375-382.
27. Decosterd I, Allchorne A, Woolf CJ. Differential analgesic sensitivity of two distinct neuropathic pain models. Anesth Analg 2004; 99: 457-463, table of contents.
28. Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977; 229: 327-336.
29. Porsolt RD, Brossard G, Hautbois C, Roux S. Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci 2001 Chapter 8: Unit 8 10A.
30. Rotllant D, Armario A. A single dose of metyrapone caused long-term dysregulation of the hypothalamic-pituitary-adrenal axis in the rat. Neuroscience 2005; 130: 427-434.
31. Craft TK, DeVries AC. Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry 2006; 60: 812-818.
32. Alexander JK, DeVries AC, Popovich PG. Stress effects on neuropathic pain. Annual Meeting of the Society for Neuroscience: Atlanta, GA, 2006.
33. Gillespie CF, Nemeroff CB. Hypercortisolemia and depression. Psychosom Med 2005; 67(Suppl 1): S26-S28.
34. DeBattista C, Belanoff J. The use of mifepristone in the treatment of neuropsychiatric disorders. Trends Endocrinol Metab 2006; 17: 117-121.
35. Dinkel K, MacPherson A, Sapolsky RM. Novel glucocorticoid effects on acute inflammation in the CNS. J Neurochem 2003; 84: 705-716.
36. de Pablos RM, Villaran RF, Arguelles S, Herrera AJ, Venero JL, Ayala A et al. Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci 2006; 26: 5709-5719.
37. MacPherson A, Dinkel K, Sapolsky R. Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures. Exp Neurol 2005; 194: 376-383.
38. Guo W, Robbins MT, Wei F, Zou S, Dubner R, Ren K. Supraspinal brain-derived neurotrophic factor signaling: a novel mechanism for descending pain facilitation. J Neurosci 2006; 26: 126-137.
39. Ceccatelli S, Ernfors P, Villar MJ, Persson H, Hokfelt T. Expanded distribution of mRNA for nerve growth factor, brain-derived neuro-trophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci USA 1991; 88: 10352-10356.
40. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 1997; 17: 2295-2313.
41. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56.
42. Wolf G, Gabay E, Tal M, Yirmiya R, Shavit Y. Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 2006; 120: 315-324.
43. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007; 10: 1361-1368.
44. Sweitzer S, Martin D, DeLeo JA. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 2001; 103: 529-539.
45. Oka T, Aou S, Hori T. Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res 1993; 624: 61-68.
46. Tonosaki Y, Nishiyama K, Roubos EW, Sugiura Y. alpha-Melanophore- stimulating hormone (alpha-MSH) antagonizes interleukin-1beta-induced hyperalgesia and Fos expression in the paraventri-cular and arcuate nucleus of the rat. Neuroendocrinology 2005; 81: 167-173.
47. Zhang RX, Li A, Liu B, Wang L, Ren K, Zhang H et al. IL-1ra alleviates inflammatory hyperalgesia through preventing phos-phorylation of NMDA receptor NR-1 subunit in rats. Pain 2008; 135: 232-239.
48. Xie W, Luo S, Xuan H, Chou C, Song G, Lv R et al. Betamethasone affects cerebral expressions of NF-kappaB and cytokines that correlate with pain behavior in a rat model of neuropathy. Ann Clin Lab Sci 2006; 36: 39-46.
49. Wang Z, Wang J, Li X, Yuan Y, Fan G. Interleukin-1 beta of Red nucleus involved in the development of allodynia in spared nerve injury rats. Exp Brain Res 2008; 188: 379-384.
50. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201-217.
51. Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 2008; 105: 751-756.
52. Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999; 40: 171-176.
53. Hayley S, Poulter MO, Merali Z, Anisman H. The pathogenesis of clinical depression: stressor-and cytokine-induced alterations of neuroplasticity. Neuroscience 2005; 135: 659-678.
54. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 1999; 4: 182-188.
55. Thomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1beta in late-life depression. Am J Psychiatry 2005; 162: 175-177.
56. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepres-sant response. Neuropsychopharmacology 2003; 28: 1182-1185.
57. Tanebe K, Nishijo H, Muraguchi A, Ono T. Effects of chronic stress on hypothalamic lnterleukin-1beta, interleukin-2, and gonadotro-phin-releasing hormone gene expression in ovariectomized rats. J Neuroendocrinol 2000; 12: 13-21.
58. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 2008; 13: 717-728.